<PAGE> 1
SCHEDULE 13G
(RULE 13d-102)
Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c)
and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Molecular Devices Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
60851C107
- --------------------------------------------------------------------------------
(CUSIP Number)
12/31/99
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act, but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
CUSIP NO. 60851C107 13G PAGE 2 OF 5 PAGES
--- ---
- --------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons
(Entities Only)
Munder Capital Management
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
State of Delaware
- --------------------------------------------------------------------------------
Number of
5 Sole Voting Power
Shares 164,656
-----------------------------------------------------
Beneficially 6 Shared Voting Power
0
Owned by -----------------------------------------------------
7 Sole Dispositive Power
Each 188,956
-----------------------------------------------------
Reporting 8 Shared Dispositive Power
Person With 0
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
188,956
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
(See Instructions)
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
2.0%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
IA
- --------------------------------------------------------------------------------
<PAGE> 3
CUSIP NO. 60851C107 13G PAGE 3 OF 5 PAGES
--- ---
ITEM 1.
(a) Name of Issuer:
Molecular Devices Corporation. (the "Company")
(b) Address of Issuer's Principal Executive Offices:
1311 Orleans Drive
Sunnyvale, CA 94089
ITEM 2.
(a) Name of Person Filing:
Munder Capital Management ("Munder")
(b) Address of Principal Business Office, if none, Residence:
Munder Capital Center
480 Pierce Street, Suite 300
P.O. Box 3043
Birmingham, MI 48012-3043
(c) Citizenship:
Munder is a general partnership formed under the laws of the
State of Delaware
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
60851C107
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
/X/ (e) Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940
<PAGE> 4
CUSIP NO. 60851C107 13G PAGE 4 OF 5 PAGES
--- ---
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned:
188,956 shares of Common Stock
(b) Percent of Class
2.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote:
164,656
(ii) shared power to vote or direct the vote:
0
(iii) sole power to dispose or to direct the disposition of:
188,956
(iv) shared power to dispose or direct the disposition of:
0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of
the date hereof, the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following |X|.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
Not Applicable
<PAGE> 5
CUSIP NO. 60851C107 13G PAGE 5 OF 5 PAGES
--- ---
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any such transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
MUNDER CAPITAL MANAGEMENT,
a Delaware general partnership
By: /s/ Terry H. Gardner
--------------------------------
Dated: 2/14/2000 Its: Vice President and CFO
